Hogehilweg 18 Mon-Fri 08:30-17:30
MijnMedicijn
📞 Contact phone — free, 24/7
Medications

Osteoporosis

Medications and supplements for maintaining and improving bone density, treating osteoporosis and reducing fracture risk. Includes prescription bone-strengthening drugs (bisphosphonates, hormone-related therapies), calcium and vitamin D supplements, and fracture-support products.

1
Products
1 products found
−25%
Calcium Carbonate
★★★★☆ 4.5 (213)
€1,65
€1,24
Buy Now

Osteoporosis

Medications and supplements for maintaining and improving bone density, treating osteoporosis and reducing fracture risk. Includes prescription bone-strengthening drugs (bisphosphonates, hormone-related therapies), calcium and vitamin D supplements, and fracture-support products.

Medicines for osteoporosis are used to help maintain or improve bone strength and reduce the risk of fractures. Osteoporosis itself is a condition characterized by reduced bone mass and structural deterioration of bone tissue, which can make bones more fragile. Treatments available in this category work in different ways — some slow down the process of bone breakdown, others stimulate new bone formation, and some support the mineral components necessary for healthy bone maintenance.

These medicines are commonly prescribed for people whose bone density has declined to a level that increases fracture risk, including some older adults, individuals with hormone-related bone loss, and people whose bones have been affected by long-term use of certain medications or medical conditions. Use patterns vary with clinical context: for some patients medication is started after a fracture or a diagnostic scan showing low bone density, while others may receive preventive treatment when risk factors are present.

There are several classes of drugs and supportive supplements found in this category. Bisphosphonates, such as alendronate (often known by its trade name Fosamax), are widely used to slow bone loss. Vitamin D analogs and active metabolites, for example alfacalcidol (Alfacip) and calcitriol (Rocaltrol), help regulate calcium metabolism and support bone mineralization. Calcium salts such as calcium carbonate are commonly used as supplements to ensure adequate dietary calcium. Other treatment options available in clinical practice include hormone-related therapies, parathyroid hormone analogs, and monoclonal antibodies that affect bone turnover; availability and use depend on individual circumstances and prescribing practices.

Medications in this area come in several forms and dosing schedules. Some are oral tablets taken periodically, others are available as liquids, and a number of modern treatments are administered by injection at intervals that can range from monthly to yearly. The choice of formulation and frequency is influenced by the specific medicine, a person’s overall health profile, and how the medicine is expected to fit into long-term management. Regular monitoring and follow-up are part of typical clinical practice to assess how well a chosen approach is working over time.

Safety considerations differ between drug classes and individual products. Commonly reported effects for some oral agents include gastrointestinal symptoms, while other therapies may be associated with changes in calcium levels, musculoskeletal discomfort, or rarer adverse events. Interactions with other medications and underlying health conditions can affect both safety and suitability. Information on potential side effects, precautions, and contraindications is an important part of product labeling and clinical decision-making.

When selecting a medicine from this category, people often consider how effective the treatment is for preventing fractures, how it is administered, how often doses are required, and the expected side effect profile. Other factors that influence choices include whether a supplement is needed alongside the primary treatment, how the medicine fits into daily life, and whether it is available over the counter or only with a prescription. Clarity about these aspects helps users weigh options and understand what to expect from different types of osteoporosis therapy.

Jeroen van den Berg
Medically reviewed by
Jeroen van den Berg
Registered Pharmacist (Apotheker), Chief Pharmacist and Head of Pharmacy Department